Red Blood Cell Disorders

precursors and progenitors to increase production of fetal hemoglobin. J Clin Invest 75: 547-557, 1985 51. Rosa RM, Bierer BE, Thomas R, Jeffrey BS, Stoff JS, Kruskall M, Robinson S, Bunn HF, Epstein FH: A study of induced hyponatremia in the prevention and treatment of sickle-cell crisis. New Eng J Med303: 1138-1143, 1980 52. Leary M, Abramson N: Induced hyponatremia for sickle-cell crisis. New Engl J Med 304: 844-845, 1980 53. Benjamin LJ, Kokkini G, Peterson CM: Cetiedil: Its potential usefulness in sickle cell disease. Blood 55: 265-270, 1980 54. Schmidt WF HI, Asakura T, Schwartz E: Effect of cetiedil on cation and water movements in eryrhrocytes. J Clin Invest 69: 589-594, 1982 55. Kaul DK, Fabry ME, Nabel RL: Pentoxifylline modifies the rheology of SS cells but does not inhibit polymerization of HbS. In Workshop on development of therapeutic agents for sickle cell disease. Lister Hill center National Institutes of Health, Betbesda, Maryland, May 15-17, 1983 56. Heilmnnn E, Laage HM, Zimmermann E, Dorst K-G: Therapeutic influence on flexibility of erythrocytes in sickle-cell anaemia. Inn Med 9: 277-280, 1982 57. Keller F, Leonhardt H: Verbesserung der blutviskositat bei sichelzellanamie durch pentoxifyllin. Dtsch Med Wschr 105: 898-900, 1980 58. SirchiaG, Lewis SM: Paroxysmal nocturnal hemoglobinuria. Clin Haematol 4: 199-229, 1975 59. Donhowe WP, Lazaro RP: Dural sins thrombosis in paroxysmal nocturnal hemoglobinuria. Clin Neurol Neurosurg 86: 149-152, 1984 60. Donhowe SP, Lazard RP: Dural sinus thrombosis in paroxysmal nocturnal hemoglobinuria. Clin Neurol Neurosurg 86: 149-152, 1984 61. Haddock DR: Cerebrovascular accidents in Ghana. Neurology (Minneap) 20: 681-686, 1970 62. Spencer JAD: Paroxysmal nocturnal hemoglobinuria in pregnancy. Br J Obstet Gynaecol 87: 246-248, 1980 63. Wozniak AJ, Kitchens CS: Prospective hemostatic studies in a patient having paroxysmal nocturnal hemoglobinuria, pregnancy, and cerebral venous thrombosis. Am J Obstet Gynecol 142: 591-593, 1982 64. Rosse WF: Treatment of paroxysmal nocturnal hemoglobinuria. Blood 60: 20-23, 1982 65. Hartmann RC, Jenkins DE Jr., McKee LC, Heyssel RM: Paroxysmal nocturnal hemoglobinuria; clinical and laboratory studies relating to iron metabolism and therapy with androgen and iron. Medicine 45: 331, 1966 66. Firkin F, Goldberg H, Firkin BG: Clucocorticoid management of paroxysmal nocturnal haemoglobinuria. Aust Ann Med 17: 127, 1968 67. Rosse WF, Gutterman LA: The effect of iron therapy in paroxysmal nocturnal hemoglobinuria. Blood 36: 559, 1970 68. Dacie JV, Firtin D: Blood transfusion in nocturnal hemoglobinuria. Br Med J 1: 626, 1943 69. Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinman L: Polycythemia vera: stem cell and probable clonal origin of the disease. N Engl J Med 295: 913-916, 1976 70. Wurster-Hill D, Whang-Peng J, Mclntyre OR, Hsu LYF, Hirschhom K, Modan B, Pisciotta AV, Pierre R, Balcerzak SP, Weinfeld A, Murphy S: Cytogenetic studies in polycythemia vera. Seminars Hematol 13: 13-32, 1976 71. Berlin NI: Diagnosis and classification of the polycythemias. Seminars Hematol 12: 339-351, 1975 72. Silverstein MN: The evolution into and the treatment of late stage polycythemia veTa. Seminars Hematol 13: 79-84, 1976 73. Silverstein A, Gilbert H, Wusserman LR: Neurologic complications of polycythemia. Ann Intern Med 57: 909-916, 1962 74. Thomas DJ, Marshall J, Ross Russell RW, et al: Cerebral blood flow in polycythemia. Lancet 2: 161-163, 1977 75. Harrison MJ: The hematocrit and cerebrovascular accidents. Presse Med 12: 3095-3097, 1983 76. Fieschi C, Iadecola C: Hemorrbeological changes in cerebrovascular disease. Ric Clin Lab 3: 189-193, 1983 77. Schmid-Schonbein H: Macrorheology and microrheology of blood in cerebrovascular insufficiency. Eur Neurol 22: Suppl 1: 2-22, 1983 78. Lechner H, Ott E: Clinical significance of changes in blood viscosity in cerebrovascular insufficiency. Munch Med Wochenschr 117: 1599-1602, 1975 79. Lowe GD, Jaap AJ, Forbes CD: Relation of atrial fibrillation and high haematocrit to mortality in acute stroke. Lancet 1: 784-786, 1983 80. Tohgi H, Uchiyama S, Ogawa M, Tabuchi M, Naguara H, Yamanouchi H: The role of blood constituents in the pathogenesis of cerebral infarction. Acta Neurol Scand 72 (suppl): 616-617, 1966 81. Chievitz E, Thiede T: Complications and causes of death in polycythemia vera. Acta Med Scand 172: 513-523, 1962 82. Siekert RG, Whisnant JP, Millikan CH: Anemia and intermittent focal cerebral arterial insufficiency. Arch Neurol 3:386-390,1960